Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis

Portal hypertension and cardiac alterations previously described as "cirrhotic cardiomyopathy" are known complications of end stage liver disease (ELD). Cardiac failure contributes to morbidity and mortality, particularly after liver transplantation and transjugular intrahepatic portosyste...

Full description

Saved in:
Bibliographic Details
Main Authors: Loßnitzer, Dirk (Author) , Steen, Henning (Author) , Zahn, Alexandra (Author) , Lehrke, Stephanie (Author) , Weiss, Celine (Author) , Weiss, Karl Heinz (Author) , Giannitsis, Evangelos (Author) , Stremmel, Wolfgang (Author) , Sauer, Peter (Author) , Katus, Hugo (Author) , Gotthardt, Daniel (Author)
Format: Article (Journal)
Language:English
Published: 13 August 2010
In: Journal of cardiovascular magnetic resonance
Year: 2010, Volume: 12, Pages: 1-10
ISSN:1532-429X
DOI:10.1186/1532-429X-12-47
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1186/1532-429X-12-47
Verlag, lizenzpflichtig, Volltext: https://jcmr-online.biomedcentral.com/articles/10.1186/1532-429X-12-47
Get full text
Author Notes:Dirk Lossnitzer, Henning Steen, Alexandra Zahn, Stephanie Lehrke, Celine Weiss, Karl Heinz Weiss, Evangelos Giannitsis, Wolfgang Stremmel, Peter Sauer, Hugo A. Katus, Daniel N. Gotthardt
Description
Summary:Portal hypertension and cardiac alterations previously described as "cirrhotic cardiomyopathy" are known complications of end stage liver disease (ELD). Cardiac failure contributes to morbidity and mortality, particularly after liver transplantation and transjugular intrahepatic portosystemic shunt (TIPS). We sought to identify myocardial tissue characterization and evaluate cardiovascular magnetic resonance (CMR) for diagnosis of cardiac impairment.
Item Description:Gesehen am 18.04.2023
Physical Description:Online Resource
ISSN:1532-429X
DOI:10.1186/1532-429X-12-47